← Insiders

RCMT

Bearish signalScored 2026-08-31 Drivers: fundamentals. Moteurs : fondamentaux.

Research, not advice.

À propos

RCM Technologies, Inc.

Nom
RCM Technologies, Inc.
Secteur
Industrials
Industrie
Conglomerates
Bourse
NASDAQ
Capitalisation
$263.2M
Employés
4,930
PDG
Bradley S. Vizi
Site web
https://www.rcmt.com
Marché
BLNKDSXFCELGENCIRSISSC

RCM Technologies, Inc. delivers business and technology-focused solutions across the United States, Canada, Puerto Rico, and Serbia. The company organizes its operations into three distinct divisions: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering division provides diverse services, including project management, design, analytical work, engineer-procure-construct (EPC) services, configuration management, hardware/software validation and verification, quality assurance, technical documentation, manufacturing process optimization, and integrated 3D/BIM design. Within its Specialty Health Care unit, RCM offers both temporary and permanent staffing, executive recruitment, and placement services. These cater to various healthcare domains such as allied health and therapy, correctional healthcare, health information management, nursing, physician and advanced practice roles, school services, and telepractice. The Life Sciences and Information Technology segment concentrates on supplying comprehensive enterprise business solutions, application services, robust infrastructure solutions, strategies for competitive advantage, specialized life sciences offerings, and tailored solutions for other specific vertical markets. RCM Technologies serves a broad spectrum of industries, including aerospace and defense, energy, financial services, healthcare, life sciences, manufacturing and distribution, and technology. Additionally, their clientele extends to educational institutions and governmental bodies. Founded in 1971, RCM Technologies, Inc. is headquartered in Pennsauken, New Jersey.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 100 000 titres (~3 606 606,60 $ US)

Insiders
Vizi Bradley
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$6,019,203

Avg sell (VWAP, 90d window) $38.32 vs last close —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

$2,713,763 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.

Last activity
2026-08-17
Last synced
2026-08-23 00:12:53 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-08-31 MILLER KEVIN D Sell · S · 10b5-1 20,271 $42.19 $855,233 Form 4
2026-08-28 MILLER KEVIN D Sell · S · 10b5-1 2,230 $42.00 $93,660 Form 4
2026-08-26 MILLER KEVIN D Sell · S 1,753 $42.05 $73,714 Form 4
2026-08-25 MILLER KEVIN D Sell · S 1,333 $42.00 $55,986 Form 4
2026-08-21 Saks Michael Sell · S 706 $41.12 $29,031 Form 4
2026-08-18 Saks Michael Sell · S 6,265 $41.24 $258,369 Form 4
2026-08-18 MILLER KEVIN D Sell · S · 10b5-1 4,413 $42.00 $185,346 Form 4
2026-08-17 MILLER KEVIN D Sell · S · 10b5-1 9,814 $39.12 $383,924 Form 4
2026-08-17 Vizi Bradley Sell · S 50,000 $40.06 $2,003,000 Form 4
2026-08-14 MILLER KEVIN D Sell · S · 10b5-1 30,000 $34.02 $1,020,600 Form 4
2026-08-14 Vizi Bradley Sell · S 25,281 $35.02 $885,341 Form 4
2026-08-14 Saks Michael Sell · S · 10b5-1 5,000 $35.00 $175,000 Form 4

Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Signal

Bearish signalScored 2026-08-31 Drivers: fundamentals. Moteurs : fondamentaux.

RCMT presents a moderately constructive setup: solid financial health recovery (liquidity score 75, fundamentals trend 65) combined with a meaningful Q2 2026 earnings beat ($0.82 vs $0.54 consensus) provide a reasonable…

The first sentence of the analysis written for RCMT on 2026-08-31 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Bearish signal Drivers: fundamentals. Moteurs : fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Congress Unavailable or mixed. No purchase disclosures in the stored window
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Timing Unavailable or mixed. No stored price series
  • Financial indicators Supports a bullish reading. Current ratio 1.85 · operating margin 7.9%

Market snapshot

Financial ratios

MetricTrend2026-01-032024-12-282023-12-302022-12-312022-01-01
Gross Profit Margin26.9%28.7%29.1%29.1%26.1%
Ebit Margin7.7%8.0%9.0%10.1%7.0%
Ebitda Margin8.7%8.8%9.4%10.5%7.5%
Operating Profit Margin7.9%8.0%9.0%10.1%6.9%
Pretax Profit Margin6.9%7.3%8.4%10.0%6.8%
Continuous Operations Profit Margin5.1%4.8%6.4%7.3%5.4%
Net Profit Margin5.1%4.8%6.4%7.3%5.4%
Bottom Line Profit Margin5.1%4.8%6.4%7.3%5.4%
Current Ratio1.8541.8091.5551.4601.741
Quick Ratio1.8541.8091.5551.4601.741
Solvency Ratio0.2200.1560.1910.3920.258
Cash Ratio0.0540.0880.1080.0080.008
Price To Earnings Ratio9.23713.47114.3055.9337.120
Price To Earnings Growth Ratio0.369-0.882-5.9510.055-0.030
Forward Price To Earnings Growth Ratio0.369-0.882-5.9510.055-0.030
Price To Earnings Diluted Ratio9.23713.79214.8166.1707.495
Price To Earnings Diluted Growth Ratio0.330-0.965-7.4080.056-0.033
Price To Book Ratio3.2895.4899.3563.8813.026
Price To Sales Ratio0.4730.6600.9170.4360.385
Price To Free Cash Flow Ratio8.70651.08425.2634.502226.432
Price To Operating Cash Flow Ratio7.97429.79019.3314.36185.871
Debt To Assets Ratio0.1930.3190.2820.1560.250
Debt To Equity Ratio0.5631.2601.3180.4300.702
Debt To Capital Ratio0.3600.5570.5690.3010.412
Long Term Debt To Capital Ratio0.3490.5110.5440.2160.353
Financial Leverage Ratio2.9233.9444.6722.7522.805
Working Capital Turnover Ratio7.1457.35410.34413.98710.930
Operating Cash Flow Ratio0.3520.1150.2140.7040.031
Operating Cash Flow Sales Ratio0.0590.0220.0470.1000.004
Free Cash Flow Operating Cash Flow Ratio0.9160.5830.7650.9690.379
Debt Service Coverage Ratio8.2767.96613.89860.27034.126
Interest Coverage Ratio9.40210.07916.93577.83238.729
Short Term Operating Cash Flow Coverage Ratio0.0000.0000.0000.0000.000
Operating Cash Flow Coverage Ratio0.7320.1460.3672.0670.050
Capital Expenditure Coverage Ratio11.8902.3994.25931.9911.611
Dividend Paid And Capex Coverage Ratio11.8902.3994.25931.9911.611
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple6.2609.02810.8434.5996.278

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 26.9% ▼-1.7% ▼-1.1%
Ebit Margin 7.8% ▼-0.3% ▼-0.6%
Ebitda Margin 8.7% ▼-0.1% ▼-0.3%
Operating Profit Margin 7.9% ▼-0.2% ▼-0.5%
Pretax Profit Margin 6.9% ▼-0.3% ▼-1.0%
Continuous Operations Profit Margin 5.1% ▲0.3% ▼-0.7%
Net Profit Margin 5.1% ▲0.3% ▼-0.7%
Bottom Line Profit Margin 5.1% ▲0.3% ▼-0.7%
Current Ratio 1.854 ▲0.044 ▲0.170
Quick Ratio 1.854 ▲0.044 ▲0.170
Solvency Ratio 0.220 ▲0.063 ▼-0.024
Cash Ratio 0.054 ▼-0.034 ▲0.001
Price To Earnings Ratio 9.237 ▼-4.234 ▼-0.776
Price To Earnings Growth Ratio 0.369 ▲1.252 ▲1.657
Forward Price To Earnings Growth Ratio 0.369 ▲1.252 ▲1.657
Price To Earnings Diluted Ratio 9.237 ▼-4.554 ▼-1.065
Price To Earnings Diluted Growth Ratio 0.330 ▲1.296 ▲1.934
Price To Book Ratio 3.289 ▼-2.200 ▼-1.719
Price To Sales Ratio 0.473 ▼-0.187 ▼-0.101
Price To Free Cash Flow Ratio 8.706 ▼-42.378 ▼-54.491
Price To Operating Cash Flow Ratio 7.974 ▼-21.816 ▼-21.491
Debt To Assets Ratio 0.193 ▼-0.127 ▼-0.048
Debt To Equity Ratio 0.563 ▼-0.696 ▼-0.291
Debt To Capital Ratio 0.360 ▼-0.197 ▼-0.080
Long Term Debt To Capital Ratio 0.349 ▼-0.162 ▼-0.045
Financial Leverage Ratio 2.923 ▼-1.021 ▼-0.496
Working Capital Turnover Ratio 7.145 ▼-0.209 ▼-2.807
Operating Cash Flow Ratio 0.352 ▲0.237 ▲0.069
Operating Cash Flow Sales Ratio 0.059 ▲0.037 ▲0.013
Free Cash Flow Operating Cash Flow Ratio 0.916 ▲0.333 ▲0.194
Debt Service Coverage Ratio 8.276 ▲0.310 ▼-16.631
Interest Coverage Ratio 9.402 ▼-0.677 ▼-21.194
Short Term Operating Cash Flow Coverage Ratio 0.000 0.000 0.000
Operating Cash Flow Coverage Ratio 0.732 ▲0.586 ▲0.060
Capital Expenditure Coverage Ratio 11.890 ▲9.491 ▲1.460
Dividend Paid And Capex Coverage Ratio 11.890 ▲9.491 ▲1.460
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 6.260 ▼-2.768 ▼-1.141

Key metrics

MetricTrend20252024202320222021
Market cap$151.2M$183.8M$241.3M$124.0M$78.6M
Enterprise value$174.2M$221.3M$269.0M$137.5M$96.6M
EV / Sales0.55x0.80x1.02x0.48x0.47x
EV / Op. cash flow9.19x35.86x21.55x4.83x105.53x
EV / Free cash flow10.03x61.49x28.16x4.99x278.27x
EV / EBITDA6.26x9.03x10.84x4.60x6.28x
Net debt / EBITDA0.83x1.53x1.12x0.45x1.17x
Current ratio1.85x1.81x1.55x1.46x1.74x
Income quality1.16x0.46x0.74x1.36x0.08x
Graham number$17$13$12$12$7
Graham net-net-$2-$4-$3-$2-$1
Tax burden74.0%66.0%75.8%73.3%79.0%
Interest burden89.2%90.1%94.1%98.7%97.4%
Working capital$46.0M$43.4M$32.3M$18.6M$22.1M
Invested capital$80.2M$78.1M$61.9M$47.4M$42.3M
Return on assets12.2%10.1%14.0%23.7%15.1%
Operating ROA18.8%17.7%22.7%35.8%20.0%
Return on tangible assets14.6%12.1%17.2%32.2%19.5%
Return on equity35.5%39.8%65.3%65.4%42.3%
Return on invested capital22.8%18.4%28.4%42.8%24.8%
Return on capital employed31.2%28.5%38.0%60.6%32.9%
Earnings yield10.8%7.3%7.0%16.8%14.0%
Free cash flow yield11.5%2.0%4.0%22.2%0.4%
Capex / Op. cash flow8.4%41.7%23.5%3.1%62.1%
Capex / Depreciation83.2%122.4%137.4%43.5%26.3%
Capex / Sales0.5%0.9%1.1%0.3%0.3%
SG&A / Sales19.1%20.4%19.8%18.8%20.6%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales1.2%1.0%0.8%0.6%0.7%
Intangibles / Total assets16.5%16.8%18.9%26.2%22.4%
Days sales outstanding102d112d110d69d88d
Days payables outstanding15d68d85d43d28d
Operating cycle102d112d110d69d88d
Cash conversion cycle87d43d25d26d61d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-17.7%EV / Sales ▼-31.4%EV / EBITDA ▼-30.7%EV / Op. cash flow ▼-26.674Earnings yield ▲+0.036Graham number ▲+4.439
Profitability
Return on equity ▼-0.043Return on assets ▲+0.021Return on invested capital ▲+0.044Return on capital employed ▲+0.027Operating ROA ▲+0.012Income quality ▲+0.698Tax burden ▲+0.080
Efficiency
Days sales outstanding ▼-9.807Days payables outstanding ▼-53.349Operating cycle ▼-9.807Cash conversion cycle ▲+43.542Capex / Sales ▼-0.004R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.044Net debt / EBITDA ▼-0.702Working capital ▲+2597000.000Invested capital ▲+2152000.000Intangibles / Total assets ▼-0.003

Change over 5 years

Valuation
Market cap ▲+92.5%EV / Sales ▲+15.2%EV / EBITDA ▼-0.3%EV / Op. cash flow ▼-96.344Earnings yield ▼-0.032Graham number ▲+9.809
Profitability
Return on equity ▼-0.068Return on assets ▼-0.029Return on invested capital ▼-0.020Return on capital employed ▼-0.017Operating ROA ▼-0.012Income quality ▲+1.078Tax burden ▼-0.050
Efficiency
Days sales outstanding ▲+13.829Days payables outstanding ▼-12.438Operating cycle ▲+13.829Cash conversion cycle ▲+26.268Capex / Sales ▲+0.002R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.113Net debt / EBITDA ▼-0.344Working capital ▲+23888000.000Invested capital ▲+37962000.000Intangibles / Total assets ▼-0.060

Employee count

Peer market caps

Recent news